CODELINOV Trademark

Trademark Overview

On Wednesday, September 18, 2013, a trademark application was filed for CODELINOV with the United States Patent and Trademark Office. The USPTO has given the CODELINOV trademark a serial number of 86068502. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 15, 2021. This trademark is owned by Takeda Pharmaceutical Company Limited. The CODELINOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of diabetic diseases
codelinov

General Information

Serial Number86068502
Word MarkCODELINOV
Filing DateWednesday, September 18, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 15, 2021
Registration Number4546858
Registration DateTuesday, June 10, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of diabetic diseases
Pseudo MarkCODE LINOV
Translation of Words in MarkThe wording "CODELINOV" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Friday, January 15, 2021CANCELLED SEC. 8 (6-YR)
Thursday, July 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 10, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 10, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 27, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 27, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 26, 2014ASSIGNED TO LIE
Wednesday, January 15, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 29, 2013NON-FINAL ACTION E-MAILED
Sunday, December 29, 2013NON-FINAL ACTION WRITTEN
Sunday, December 29, 2013ASSIGNED TO EXAMINER
Friday, September 27, 2013NOTICE OF PSEUDO MARK E-MAILED
Thursday, September 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 21, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

codelinov diabetic diseases prevention treatment preparations pharmaceutical